Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers [Phase 2]

View source ↗

Summary

Phase 2 trial updating immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine in healthy toddlers; results posted after co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infections
• Meningococcal Meningitis

Drugs mentioned

• Investigational quadrivalent meningococcal conjugate vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Meningitis | Phase 2 | Status: COMPLETED | Results posted: 2020-06-05